ARRAY BIOPHARMA
   
 

Welcome to Array BioPharma

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and inflammatory diseases. Our proprietary drug development pipeline includes clinical candidates that are designed to regulate therapeutically important target proteins and are aimed at significant unmet medical needs. In addition, leading pharmaceutical and biotechnology companies collaborate with Array to discover and develop drug candidates across a broad range of therapeutic areas.

Latest News and Press Releases:
1/23/2012 Array BioPharma to Report Financial Results for the Second Quarter of Fiscal 2012 on January 30, 2012
1/16/2012 Array BioPharma's Chief Executive Officer Robert E. Conway Resigns
1/4/2012 Array BioPharma to Present at the 30th Annual J.P. Morgan Healthcare Conference
12/11/2011 ARRY-614 Demonstrates Positive Single Agent Activity in Patients with Myelodysplastic Syndromes
 
Email this page
Printer friendly version
   
Array Analyst Day